Regional individual allergen based miniscreen to predict IgE-mediated airborne allergy.
A small panel of local individual regional allergens (miniscreen) tested in vitro by FAST was developed to evaluate the utility of screening for IgE-mediated airborne allergy. Using this miniscreen in a population of 125 subjects referred for evaluation of possible allergic respiratory disorders would have increased the accuracy of referral from 74.4% to 95.6%. The miniscreen correctly classified 119 of the 125 subjects. The miniscreen appears to be a potentially useful tool for the allergy specialist in the present medical climate.